Conference Programme

Registration

Welcome Remarks

Harnessing the Body’s Defences

Researchers are discovering that many answers to disease prevention and treatment lie within the immune system itself, rather than solely relying on synthetic drugs. This session will showcase innovative approaches that harness the immune system to develop novel immunotherapies that provide more effective treatments for patients.

• Keynote presentation
• 2 Company Case Studies – Jake Galson, Alchemab
• Panel discussion
  – Panellists: Lennart Spindler, SV Health Investors, Jake Galson, Alchemab

Morning Coffee and Networking Break

Adoption of AI in Innovative Drug Discovery

As AI advances in drug discovery, how does our sector strike the right balance between innovation and ensuring it is used responsibly, that will determine what we can adopt to maximise its impact.

• Keynote presentation
• 2 Company Case Studies
• Panel discussion
  – Panellists: Peter Brady, Orbital Global Group, Rose Hughes, AstraZeneca

Lunch and Networking

Getting Ready for Clinic: Transformative Technologies

Tools such as organ-on-a-chip technology and biobanks are transforming the pre-clinical space. This session will highlight the changing pre-clinical research space, leading to enhanced clinical readiness by streamlining data collection, improved disease modelling, and facilitating collaboration among research teams, ultimately accelerating the transition from lab to clinic.

• Keynote presentation
• 2 Company Case Studies – Catherine Stace, Kuano Limited
• Panel discussion
  – Panellists: Catherine Stace, Kuano Limited, Marin Mladinic, PPD

Afternoon Coffee and Networking Break

Invention, Innovation, Industrialisation: How to Accelerate the Journey?

Session Sponsored by:

This session will consider the challenges of translating disruptive innovation to industrial scale adoption. What lessons can be learned from past successes and current trends? There will also be an opportunity to hear insights from an international ecosystem in the way of key learnings from the Boston Bootcamp 2025.

• Panel discussion: Scaling Innovation for Industrial Adoption
  – Moderator: Mike Ward, Clarivate
  – Panellists: Cathy Tralau-Stewart, The Milner Therapeutics Institute and Consortium, speaker tbc, LifeArc
• Keynote presentation – speaker tbc, LifeArc
• Panel discussion: Key Learnings from the Boston Bootcamp 2025
  – Panellists: speaker tbc, Metrion Biosciences, Hannah Sore, PharmEnable Therapeutics, Priya Mande, RNAvate, Jason Yip, Tailor Bio

Closing Remarks

Tony Jones, One Nucleus

Networking Drinks Reception

End